Polymersomes preventing brain infiltration of CD177+ neutrophils to mitigate hemorrhagic transformation post-tPA thrombolysis
Open Access
- 25 March 2026
- journal article
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Abstract
As an intravenous thrombolytic agent, tissue plasminogen activator (tPA) is limited by hemorrhagic transformation (HT) and a narrow therapeutic time window. Here we develop ROS-triggered polymersomes conjugated with fibrin-targeting CREKA peptide (CP) for tPA encapsulation. CP@tPA achieves efficient thrombosis targeting and enhanced thrombolytic efficacy, however, it has not been able to avert the occurrence of hemorrhage subsequent to thrombolysis. Building from our clinical discovery that stroke patients suffer from tPA-induced HT featured strong expression of CD177 , recombinant CD177 protein (rCD177) was loaded into CP polymersomes (CP@rCD177) as nanomedicine and administrated prior to CP@tPA thrombolysis. rCD177 can be released in response to elevated ROS within the obstructed vessels, which binds to endothelial cells through interacting with CD31 and efficiently prevents the migration of CD177 + neutrophils into the brain parenchyma. The reduced CD177 + neutrophils suppress the generation of neutrophil extracellular traps (NETs), thereby dampening the inflammatory activation of microglia and ultimately improving the prognosis of HT. This innovative strategy presents a promising avenue for attenuating hemorrhagic complications post-thrombolysis.Keywords
Funding Information
- National Natural Science Foundation of China (U22A20161, 52495011, 52473324)
This publication has 76 references indexed in Scilit:
- Nanoparticle delivery systems mitigate hemorrhagic complications following tPA-induced thrombolysisScience China Technological Sciences, 2025
- Discoidal nanoparticles exploit thrombus-induced shear gradients to enhance site-specific thrombolysis in strokeActa Biomaterialia, 2025
- M2 Macrophage‐Derived Exosomes Inhibiting Neutrophil Extracellular Traps for Ischemic Stroke TherapyAdvanced Functional Materials, 2024
- A Homing Peptide Modified Neutrophil Membrane Biomimetic Nanoparticles in Response to ROS/inflammatory Microenvironment for Precise Targeting Treatment of Ischemic StrokeAdvanced Functional Materials, 2023
- A “Nano‐Courier” for Precise Delivery of Acetylcholine and Melatonin by C5a‐Targeted Aptamers Effectively Attenuates Reperfusion Injury of Ischemic StrokeAdvanced Functional Materials, 2023
- Rod‐Shaped Polymeric Nanoparticles Intervene Neutrophils for Efficient Ischemic Stroke TherapyAdvanced Functional Materials, 2023
- NIR‐II Hydrogen‐Bonded Organic Frameworks (HOFs) Used for Target‐Specific Amyloid‐β Photooxygenation in an Alzheimer's Disease ModelAngewandte Chemie International Edition, 2021
- Microthrombus‐Targeting Micelles for Neurovascular Remodeling and Enhanced Microcirculatory Perfusion in Acute Ischemic StrokeAdvanced Materials, 2019
- Microenvironment Remodeling Micelles for Alzheimer's Disease Therapy by Early Modulation of Activated MicrogliaAdvanced Science, 2018
- Targeted Antithrombotic Protein MicellesAngewandte Chemie International Edition, 2014